Caxton Associates (New York)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-85,544
| Closed | -$1.15M | – | 690 |
|
|
2023
Q1 | $1.15M | Buy |
85,544
+8,880
| +12% | +$119K | 0.17% | 117 |
|
|
2022
Q4 | $948K | Sell |
76,664
-5,694
| -7% | -$70.4K | 0.06% | 108 |
|
|
2022
Q3 | $1.15M | Buy |
82,358
+39,705
| +93% | +$554K | 0.15% | 73 |
|
|
2022
Q2 | $589K | Hold |
42,653
| – | – | 0.06% | 219 |
|
|
2022
Q1 | $694K | Sell |
42,653
-13,420
| -24% | -$218K | 0.06% | 149 |
|
|
2021
Q4 | $913K | Buy |
+56,073
| New | +$913K | 0.09% | 112 |
|